At this time, posts about L&K Bio are rapidly increasing on portals and stock communities, and today, foreign investors are tentatively estimated to have net purchased 20,517 shares. L&K Bio is known as a company that develops, manufactures, and sells spinal implants.


As of 1:30 PM on the 29th, L&K Bio's stock price is 38,600 KRW, down 7.99% from the previous day, with a trading volume of 477,384 shares, which is 67.6% of the 5-day average trading volume. On January 27th, L&K Bio became a market issue with the announcement of a spinal implant contract with the Japanese Kyocera Group, which has sales of 16 trillion KRW.


In addition to L&K Bio, posts by investors are also rapidly increasing for Interpark (035080), Design (227100), and Me2on (201490).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing